You are here

Theramed Health Corporation

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Technology
Symbol: 
TMED
CSE Index: 
Currency: 

Theramed Health Corporation (formerly EviTrade Health Systems) is a Technology company specializing in the Life Sciences sector.  The company is focused on providing technologies that improve health conditions.

The Company's is focused on technologies in the following areas to help improve health:

1) health monitoring via the TULIP(TM) system that can be utilized for CBD usage monitoring for its effects on your cardiovascular and endocannabinoid system;

2) molecular biology and technologies through a novel slow release pharmaceutical carrier system to increase water solubility and absorption of CBD or other Active Pharamceutical Ingredients (APIs);

3) technologies for CBD extractions for improved purity and extractions of nutraceutical solutions and other APIs;

4) and genetics.

Theramed Health seeks to be the first company to offer a complete vertically integrated “CBD Health System” from extraction to pharmaceuticals to monitoring the health outcomes

 

 

You are here

Theramed Health Corporation (TMED)

SEDAR Information

Company Info

Address
5728 E Boulevard
Vancouver, BC V6M 4M4
Canada
Phone
604-780-3311
Email
theramedhealthcorp@gmail.com
Website
http://www.theramedhealthcorp.com
Listing date
Thursday, June 20, 2013
Transfer Agent
National Securities Administrators Ltd.
Investor Relations
Pls contact the company for information. Thank you.
Auditor
Charlton and Co. CPAs

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
117,954,638
Reserved for Issuance: 
24,510,773

Bulletins

22/10/2019

2019-1011 – Name Change and Consolidation - Theramed Health Corporation (TMED)

Le 22 octobre/October 2019

Theramed Health Corporation  has announced a name and symbol change to EGF Theramed Health Corp.  

The symbol will remain (TMED).

Theramed Health has also announced a consolidation of its issued and outstanding share capital on the basis of one hundred (100) pre-consolidation shares for every one (1) post-consolidation common share.

As a result, the outstanding shares of the company will be reduced to approximately 1,116,912.

Advertisement

Publicité

Latest CSE News

Upcoming Events

10_22_Benzinga_Capital_Conference_Chicago_Website

Benzinga Capital Conference Chicago

Tuesday, October 22, 2019 (All day) to Wednesday, October 23, 2019 (All day)
10_23_XPLOR_2019_Website

XPLOR 2019

Wednesday, October 23, 2019 (All day) to Thursday, October 24, 2019 (All day)
10-23_Cannabis_World_Congress_Business_Exposition-Website

Cannabis World Congress & Business Exposition

Wednesday, October 23, 2019 (All day) to Saturday, October 26, 2019 (All day)